Hardman Johnston Global Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-47,758
Closed -$4.4M 72
2018
Q4
$4.4M Sell
47,758
-1,750
-4% -$154K 0.23% 45
2018
Q3
$4.68M Hold
49,508
0.2% 47
2018
Q2
$4.59M Hold
49,508
0.19% 46
2018
Q1
$4.69M Sell
49,508
-100
-0.2% -$11K 0.2% 47
2017
Q4
$4.8M Sell
49,608
-800
-2% -$75.4K 0.2% 48
2017
Q3
$4.48M Sell
50,408
-616
-1% -$46.9K 0.19% 49
2017
Q2
$3.7M Hold
51,024
0.16% 54
2017
Q1
$3.33M Sell
51,024
-312
-0.6% -$19.6K 0.15% 53
2016
Q4
$3.21M Sell
51,336
-314
-0.6% -$19.2K 0.16% 53
2016
Q3
$3.26M Hold
51,650
0.15% 53
2016
Q2
$3.2M Hold
51,650
0.16% 55
2016
Q1
$2.95M Sell
51,650
-2,849
-5% -$159K 0.17% 52
2015
Q4
$3.23M Buy
54,499
+3,548
+7% +$204K 0.21% 47
2015
Q3
$2.77M Hold
50,951
0.18% 45
2015
Q2
$3.42M Hold
50,951
0.2% 45
2015
Q1
$2.98M Hold
50,951
0.18% 47
2014
Q4
$3.33M Hold
50,951
0.18% 50
2014
Q3
$2.94M Hold
50,951
0.16% 49
2014
Q2
$2.88M Hold
50,951
0.15% 54
2014
Q1
$2.62M Hold
50,951
0.15% 55
2013
Q4
$2.69M Sell
50,951
-2,000
-4% -$98.3K 0.18% 52
2013
Q3
$2.37M Buy
52,951
+200
+0.4% +$8.87K 0.16% 52
2013
Q2
$2.18M Buy
+52,751
New +$2.31M 0.15% 57

Other funds holding ABBV

Hardman Johnston Global Advisors's ABBV Position: Q1 2019 in Review

Hardman Johnston Global Advisors sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 47,758 shares — an estimated $4.4M sold.

Hardman Johnston Global Advisors first reported a position in ABBV in Q2 2013 and held it in 23 quarters. The position peaked at $4.8M in Q4 2017. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • Hardman Johnston Global Advisors reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
  • Hardman Johnston Global Advisors sold 47,758 AbbVie shares in Q1 2019, an estimated $4.4M.
  • Hardman Johnston Global Advisors first reported a position in AbbVie in Q2 2013 and held it in 23 quarters.
  • Hardman Johnston Global Advisors's AbbVie position peaked at $4.8M in Q4 2017.
  • 2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Hardman Johnston Global Advisors's 13F filing for Q1 2019, filed 3 May 2019.